GLYCOSYNTH LIMITED

GLYCOSYNTH LIMITED is a biopharma and manufacturing company founded in 1923. The company's slogan revolves around creating innovative substrates for various advanced applications in clinical, food, environmental microbiology, plant molecular biology, and diagnostics. Specializing in the production of chromogenic substrates, fluorogenic substrates, and carbohydrates with patented substrates, Glycosynth's products find extensive use in clinical, food, and environmental microbiology, plant molecular biology, and general diagnostics. They offer a wide variety of substrates including 4-methylumbelliferyl (4mu), nitrophenyl, 7-amido-4-methylcoumarin (amc), indolyl, naphthyl, and other substrates, alongside a new collection of patented products. Currently, there is no available information about the headquarters, last investment, or last investment investors.